Skip to main navigation
Header Menu
Logo
  • About
    • Overview
    • Management
    • Board of Directors
  • Products
    • SYMJEPI® (epinephrine)
    • ZIMHI™ (naloxone)
  • Pipeline
  • Patients
  • Investors & Media
    • Overview
    • News Releases
    • Stock Information
    • SEC Filings
    • Events & Presentations
    • Email Alerts
    • Governance
  • Partnerships
  • Contact Us

Corporate Governance

Committee Charters

Audit Committee Charter
Compensation Committee Charter
Nominating and Governance Committee Charter

Other Governance Documents

Corporate Governance Guidelines
Code of Business Conduct and Ethics

Sign Up For Adamis Pharmaceuticals Email Alerts

Choose Your Preferences
Adamis

Adamis Pharmaceuticals is a clinical stage neuro-biotechnology company focused on the development and commercialization of potential blockbuster products for the treatment of a variety of neuro-based disorders with significant unmet medical needs.

02. Footer - Social Links
  • LinkedIn
  • Twitter
Footer - Column 2
COMPANY
  • About Us
  • Overview
  • Management
  • Board of Directors
Products
  • SYMJEPI® (epinephrine)
  • ZIMHI® (naloxone)
Pipeline
  • Specialty Pharmaceuticals
  • APC-400 (tempol) – Capsule
Footer - Column 3 (Hidden on Desktop)
Investors & Media
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events & Presentations
  • Email Alerts
  • Corporate Governance
Connect
  • Careers
  • Partnerships
  • Contact Us
Footer - Column 4
Products
  • SYMJEPI® (epinephrine)
  • ZIMHI® (naloxone)
Pipeline
  • New Molecular Entities
Footer - Column 5
Investors & Media
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events & Presentations
  • Corporate Governance
  • Email Alerts
Footer - Column 6
Connect
  • Careers
  • Partnerships
  • Contact Us

© 2023 Copyright Adamis Pharmaceuticals Corp

Footer Copyright Links
  • Terms and Conditions
  • Privacy Policy